These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 15287937

  • 1. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL.
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [Abstract] [Full Text] [Related]

  • 2. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP, Deitcher SR.
    Arch Intern Med; 2004 Oct 11; 164(18):1965-76. PubMed ID: 15477430
    [Abstract] [Full Text] [Related]

  • 3. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.
    Arch Intern Med; 1997 Jul 28; 157(14):1522-30. PubMed ID: 9236553
    [Abstract] [Full Text] [Related]

  • 4. Hormone therapy and thromboembolic disease.
    Battaglioli T, Martinelli I.
    Curr Opin Hematol; 2007 Sep 28; 14(5):488-93. PubMed ID: 17934355
    [Abstract] [Full Text] [Related]

  • 5. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2007 Feb 20; 115(7):840-5. PubMed ID: 17309934
    [Abstract] [Full Text] [Related]

  • 6. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G.
    Arch Intern Med; 2003 May 12; 163(9):1105-9. PubMed ID: 12742811
    [Abstract] [Full Text] [Related]

  • 7. Sex and gender issues and venous thromboembolism.
    Moores L, Bilello KL, Murin S.
    Clin Chest Med; 2004 Jun 12; 25(2):281-97. PubMed ID: 15099889
    [Abstract] [Full Text] [Related]

  • 8. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Jun 12; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 9. [Venous and arterial thrombotic events induced by synthetic-steroid hormones or oral contraceptives].
    Sugawara H, Kawakami M.
    Nihon Rinsho; 1999 Jul 12; 57(7):1657-64. PubMed ID: 10429474
    [Abstract] [Full Text] [Related]

  • 10. Thromboembolism in women.
    Martinelli I.
    Semin Thromb Hemost; 2006 Oct 12; 32(7):709-15. PubMed ID: 17024598
    [Abstract] [Full Text] [Related]

  • 11. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J, Gompel A.
    Rev Prat; 2007 Apr 15; 57(7):759-66. PubMed ID: 17626321
    [Abstract] [Full Text] [Related]

  • 12. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
    Sidney S, Petitti DB, Soff GA, Cundiff DL, Tolan KK, Quesenberry CP.
    Contraception; 2004 Jul 15; 70(1):3-10. PubMed ID: 15208046
    [Abstract] [Full Text] [Related]

  • 13. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 15; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 14. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
    Samuelsson E, Hägg S.
    Acta Obstet Gynecol Scand; 2004 Jul 15; 83(7):674-81. PubMed ID: 15225194
    [Abstract] [Full Text] [Related]

  • 15. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

  • 16. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Lacut K, White RH, Vickars L, Rodger M.
    Thromb Haemost; 2010 Sep 12; 104(3):498-503. PubMed ID: 20539910
    [Abstract] [Full Text] [Related]

  • 17. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J.
    Arch Intern Med; 2007 Feb 12; 167(3):282-9. PubMed ID: 17296885
    [Abstract] [Full Text] [Related]

  • 18. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F, Gaspard U.
    J Pharm Belg; 2004 Feb 12; 59(1):38-40. PubMed ID: 15129579
    [Abstract] [Full Text] [Related]

  • 19. [Hormone therapy and cardiovascular risk].
    Wütschert R, Cirafici P.
    Praxis (Bern 1994); 2000 Jun 29; 89(25-26):1090-7. PubMed ID: 11367591
    [Abstract] [Full Text] [Related]

  • 20. Women's issues in venous thromboembolism.
    Ornstein DL, Cushman M.
    Curr Hematol Rep; 2004 Sep 29; 3(5):382-8. PubMed ID: 15341707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.